I guess when it rains it pours. GforGames relays a report via Laoyaoba, which claims that Apple’s iWatch is awaiting certification from U.S. Food and Drug Administration (FDA), before the company starts mass production of the device for a launch later this fall.
This comes hot on the heels of reports from Reuters, which claimed that Apple will launch an iWatch with a surprisingly large 2.5-inch display, wireless charging capabilities, and also feature a plethora of sensors, followed by a report by Wall Street Journal, which claimed that Apple is planning to launch iWatch in multiple sizes with over 10 sensors including ones to track health and fitness.
The report claims that according to their sources, Apple has already finalized the design and specifications of the device, and is working to get the iWatch certified as a medical equipment from the FDA. The iWatch will come with wide range of biometric sensors including heart rate, blood pressure and blood glucose sensor. The report also claims that Apple has developed an in-house sweat analysis sensor for the iWatch.
Initial reports had indicated that the iWatch will include sensors to monitor heart rate, blood pressure etc. But then we started hearing contradictory reports which claimed was designing a much simpler device, so that it doesn’t need FDA approval. Some experts have also argued that non-invasive continuous glucose monitoring (CGM) technology is still in its infancy, and it’s to early for it to be included in a mainstream consumer product. The report claimed that Apple’s goal was to move fitness tracking beyond the exercise-obsessed and bring it to the mass market. As such, the device will likely be a small step above the current generation of fitness trackers like the Fitbit Force.
There is however enough evidence to suggest that Apple will eventually launch a device that would include such sensors as it has been assembling a dream team of over 200 employees to work on the device. Many of these employees are new hires that Apple has lured away from well-known medical and health sensor companies like Masimo and Philips. Apple has also been having several meetings with the FDA.
It remains to be seen if the first generation iWatch will include these sensors or it will be the future iterations of the device that’ll benefit from the medical and sensor expertise Apple has been bringing into the company.
Apple is expected to unveil the iWatch at a special event in October.